DE3889057D1 - Verbindungen für die Induktion der in vitro- und in vivo-Erzeugung von Cytokinen. - Google Patents

Verbindungen für die Induktion der in vitro- und in vivo-Erzeugung von Cytokinen.

Info

Publication number
DE3889057D1
DE3889057D1 DE3889057T DE3889057T DE3889057D1 DE 3889057 D1 DE3889057 D1 DE 3889057D1 DE 3889057 T DE3889057 T DE 3889057T DE 3889057 T DE3889057 T DE 3889057T DE 3889057 D1 DE3889057 D1 DE 3889057D1
Authority
DE
Germany
Prior art keywords
carbons
carbon atoms
compounds
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3889057T
Other languages
English (en)
Other versions
DE3889057T2 (de
Inventor
Michael Albeck
Benjamin Sredni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3889057D1 publication Critical patent/DE3889057D1/de
Application granted granted Critical
Publication of DE3889057T2 publication Critical patent/DE3889057T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D329/00—Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3889057T 1987-10-09 1988-10-10 Verbindungen für die Induktion der in vitro- und in vivo-Erzeugung von Cytokinen. Expired - Fee Related DE3889057T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/107,131 US4962207A (en) 1985-09-30 1987-10-09 Organic derivatives of tellurium and selenium

Publications (2)

Publication Number Publication Date
DE3889057D1 true DE3889057D1 (de) 1994-05-19
DE3889057T2 DE3889057T2 (de) 1994-08-11

Family

ID=22315021

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3889057T Expired - Fee Related DE3889057T2 (de) 1987-10-09 1988-10-10 Verbindungen für die Induktion der in vitro- und in vivo-Erzeugung von Cytokinen.

Country Status (6)

Country Link
US (1) US4962207A (de)
EP (1) EP0311138B1 (de)
JP (1) JP2749596B2 (de)
AT (1) ATE104292T1 (de)
DE (1) DE3889057T2 (de)
ES (1) ES2051814T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946437A (en) * 1988-12-02 1990-08-07 Bar-Ilan University Method for the stimulation of bone marrow cells
AU699442B2 (en) * 1994-12-15 1998-12-03 Baker Norton Pharmaceuticals, Inc. Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
US6482311B1 (en) 2000-08-01 2002-11-19 Tda Research, Inc. Methods for suppression of filamentous coke formation
US7045150B2 (en) * 2001-07-31 2006-05-16 Tellus Biotech Ltd. Tellurium containing nutrient formulation and process for enhancing the cumulative weight gain or feed efficacy in poultry
AU2004304716B2 (en) * 2003-12-18 2010-05-27 Biomas Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
JP4903057B2 (ja) * 2004-01-22 2012-03-21 バイオマス リミテッド いぼをテルル化合物により治療するための治療法および医薬組成物
CA2580642C (en) * 2004-09-17 2014-09-02 Biomas, Ltd. Novel tellurium compounds and their use as immunomodulators
CA2580805A1 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Use of tellurium compounds as adjuvants
WO2007032009A2 (en) * 2005-09-15 2007-03-22 Biomas Ltd. Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
LT2826371T (lt) 2007-11-23 2019-06-25 Feramda Ltd. Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius
US20120157519A1 (en) 2009-06-16 2012-06-21 Biomas Ltd. Tellerium-containing compounds for treating viral infections
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11730761B2 (en) 2016-02-18 2023-08-22 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239846A (en) * 1978-04-10 1980-12-16 Eastman Kodak Company Tellurium (IV) compounds and compositions
US4508662A (en) * 1983-03-24 1985-04-02 The United States Of America As Represented By The Secretary Of The Air Force Pentafluorotelluriumoxide fluorocarbons
US4761490A (en) * 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production

Also Published As

Publication number Publication date
JP2749596B2 (ja) 1998-05-13
ATE104292T1 (de) 1994-04-15
EP0311138A2 (de) 1989-04-12
EP0311138B1 (de) 1994-04-13
EP0311138A3 (en) 1990-07-18
ES2051814T3 (es) 1994-07-01
US4962207A (en) 1990-10-09
JPH01238580A (ja) 1989-09-22
DE3889057T2 (de) 1994-08-11

Similar Documents

Publication Publication Date Title
DE3889057D1 (de) Verbindungen für die Induktion der in vitro- und in vivo-Erzeugung von Cytokinen.
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
DE3272792D1 (en) Process for the preparation of 2-penem compounds
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
KR0141683B1 (en) Naphthoic acid derivative
ES8701156A1 (es) Un procedimiento para producir un derivado de 2-(3,5-dial- quil-4-hidroxifenil)indol
ES8505922A1 (es) Procedimiento para preparar nuevos derivados del acido 4-fenil-4-oxo-buten-2-oico
DE3174132D1 (en) New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
ES8501770A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
HUP9700914A2 (hu) Kondenzált vázas, kéntartalmú heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
HUP9802645A2 (hu) Új metalloproteináz inhibitorok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
ES8602712A1 (es) Un procedimiento para preparar un derivado de rodanina
IL85253A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
HUT34478A (en) Process for producing hexahydro-pyrrolo/2.1-a/isoquinoline derivatives and pharmaceutical compositions containing them
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
DE69406763D1 (de) Pyridazinon Derivate, Herstellungsverfahren und Verwendung
ES8505656A1 (es) Procedimiento para la preparacion de quinolinonas-4
GB1032377A (en) Asymmetrical pyridoxolyl disulphides and their preparation
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee